We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
-$36.6M
Cap. Flow
-$73.8M
Cap. Flow %
-0.42%
Top 10 Hldgs %
30.57%
Holding
716
New
41
Increased
319
Reduced
225
Closed
41

Top Buys

Rank Stock Value
1
WM icon
Waste Management
WM
+$59.7M
2
MSFT icon
Microsoft
MSFT
+$55.1M
3
MA icon
Mastercard
MA
+$53.2M
4
LRCX icon
Lam Research
LRCX
+$52M
5
WMT icon
Walmart Inc
WMT
+$52M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$71.1M
2
UNH icon
UnitedHealth
UNH
+$65.8M
3
AMGN icon
Amgen
AMGN
+$58M
4
IQV icon
IQVIA
IQV
+$50.8M
5
CSCO icon
Cisco
CSCO
+$40.3M

Sector Composition

Rank Sector Weight
1 Technology 33.5%
2 Healthcare 24.06%
3 Financials 11.65%
4 Consumer Discretionary 8.41%
5 Industrials 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OKTA icon
176
Okta
OKTA
$22.9B
$18.6M 0.11%
235,650
+139,877
+146% +$10.8M
NTRA icon
177
Natera
NTRA
$36.1B
$18.4M 0.11%
116,438
-190,177
-62% -$27.7M
STN icon
178
Stantec
STN
$8.05B
$18.3M 0.11%
233,995
-71,457
-23% -$5.93M
DKS icon
179
Dick's Sporting Goods
DKS
$18.7B
$18.2M 0.1%
79,623
+72,500
+1,018% +$15.2M
AZO icon
180
AutoZone
AZO
$51.4B
$18M 0.1%
5,637
-394
-7% -$1.25M
THC icon
181
Tenet Healthcare
THC
$21.9B
$17.9M 0.1%
142,001
+52,491
+59% +$7.8M
ITCI
182
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$17.9M 0.1%
214,320
+50,188
+31% +$4.12M
ILMN icon
183
Illumina
ILMN
$29.1B
$17.9M 0.1%
133,872
-4,398
-3% -$626K
FTV icon
184
Fortive
FTV
$19.6B
$17.8M 0.1%
315,514
-188,402
-37% -$10.8M
MIRM icon
185
Mirum Pharmaceuticals
MIRM
$6.86B
$17.8M 0.1%
429,731
-78,744
-15% -$3.28M
CM icon
186
Canadian Imperial Bank of Commerce
CM
$107B
$17.7M 0.1%
279,333
-17,369
-6% -$1.1M
SYY icon
187
Sysco
SYY
$41.3B
$17.6M 0.1%
230,133
+175,390
+320% +$13.4M
ANET icon
188
Arista Networks
ANET
$201B
$17.5M 0.1%
158,543
-7,497
-5% -$771K
APLS
189
DELISTED
Apellis Pharmaceuticals
APLS
$17.2M 0.1%
539,602
-140,456
-21% -$4.22M
DNLI icon
190
Denali Therapeutics
DNLI
$3.74B
$17M 0.1%
832,977
-109,181
-12% -$2.8M
MTD icon
191
Mettler-Toledo International
MTD
$28B
$16.4M 0.09%
13,364
+6,115
+84% +$7.98M
TMUS icon
192
T-Mobile US
TMUS
$199B
$16.2M 0.09%
73,233
+17,721
+32% +$4.03M
IEX icon
193
IDEX
IEX
$16.7B
$16.1M 0.09%
77,133
-723
-0.9% -$158K
CME icon
194
CME Group
CME
$93.6B
$16M 0.09%
68,884
+42,413
+160% +$9.75M
ZBRA icon
195
Zebra Technologies
ZBRA
$12.7B
$15.8M 0.09%
40,966
-26,779
-40% -$10.4M
VZ icon
196
Verizon
VZ
$204B
$15.8M 0.09%
394,748
+32,048
+9% +$1.35M
ADI icon
197
Analog Devices
ADI
$178B
$15.7M 0.09%
73,922
-948
-1% -$210K
ROP icon
198
Roper Technologies
ROP
$38.9B
$15.7M 0.09%
30,162
+8,373
+38% +$4.6M
FICO icon
199
Fair Isaac
FICO
$30.7B
$15.7M 0.09%
7,871
+5,510
+233% +$11.8M
DFS
200
DELISTED
Discover Financial Services
DFS
$15.6M 0.09%
89,855
-22,200
-20% -$3.64M
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2024 Portfolio in Review

As of Q4 2024, Candriam SCA held 716 positions worth $17.4B, down 0.21% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Candriam SCA's Q4 2024 filing shows 41 new, 319 increased, 225 reduced and 41 closed positions. Its largest new stake was Lam Research: 685,631 shares worth $49.5M. The largest sale was Alphabet (Google) Class A, an estimated $71.1M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2024 buy was Lam Research: 685,631 shares worth $49.5M.
  • Candriam SCA added most to Waste Management in Q4 2024, an estimated $59.7M increase.
  • Candriam SCA's biggest Q4 2024 reduction was Alphabet (Google) Class A, cutting an estimated $71.1M.
  • Candriam SCA fully exited Kanzhun in Q4 2024, selling an estimated $22.5M.
  • Candriam SCA's ten largest holdings make up 31% of its $17.4B portfolio in Q4 2024.
  • Candriam SCA opened 41 new positions and closed 41 in Q4 2024.
  • Candriam SCA's portfolio value fell 0.21% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q4 2024, filed 7 Feb 2025.